Literature DB >> 16627995

p38 MAPK in development and cancer.

Cynthia Bradham1, David R McClay.   

Abstract

p38 is a MAPK that has been shown to induce a wide variety of biological effects in cell culture in response to a wide range of stimuli. These effects are dependent not only on the stimuli, but also on the cellular context, resulting in a bewildering array of possibilities. For example, p38 was shown to induce apoptosis in some cells, but prevent apoptosis in others. Similarly opposed effects had been observed with respect to cell cycle regulation. The role of p38 in inflammatory disease has been appreciated from the beginning, since it was initially identified as an cytokine inducer. More recently, p38 function has been evaluated in vivo, and through these studies p38 has emerged as an important regulator of both embryonic development and cancer progression. This review will focus on these in vivo studies in an effort to provide perspective on p38 biologically and as a pharmacological target.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627995     DOI: 10.4161/cc.5.8.2685

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  78 in total

1.  Loss of genomic imprinting in mouse embryos with fast rates of preimplantation development in culture.

Authors:  Brenna A Market Velker; Michelle M Denomme; Mellissa R W Mann
Journal:  Biol Reprod       Date:  2012-05-10       Impact factor: 4.285

2.  Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.

Authors:  Nicole Maphis; Guixiang Xu; Olga N Kokiko-Cochran; Shanya Jiang; Astrid Cardona; Richard M Ransohoff; Bruce T Lamb; Kiran Bhaskar
Journal:  Brain       Date:  2015-03-31       Impact factor: 13.501

3.  Using knowledge-driven genomic interactions for multi-omics data analysis: metadimensional models for predicting clinical outcomes in ovarian carcinoma.

Authors:  Dokyoon Kim; Ruowang Li; Anastasia Lucas; Shefali S Verma; Scott M Dudek; Marylyn D Ritchie
Journal:  J Am Med Inform Assoc       Date:  2017-05-01       Impact factor: 4.497

Review 4.  p38(MAPK): stress responses from molecular mechanisms to therapeutics.

Authors:  Lydia R Coulthard; Danielle E White; Dominic L Jones; Michael F McDermott; Susan A Burchill
Journal:  Trends Mol Med       Date:  2009-08-06       Impact factor: 11.951

5.  MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches.

Authors:  Seyed Hamid Aghaee-Bakhtiari; Ehsan Arefian; Mahmood Naderi; Farshid Noorbakhsh; Vahideh Nodouzi; Mojgan Asgari; Pezhman Fard-Esfahani; Reza Mahdian; Masoud Soleimani
Journal:  Tumour Biol       Date:  2015-01-22

6.  Matrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer.

Authors:  Xiao-Yang Wang; Abeba Demelash; Heungnam Kim; Sandra Jensen-Taubman; El Habib Dakir; Laurent Ozbun; Michael J Birrer; R Ilona Linnoila
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

7.  EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK.

Authors:  Kelly L Mueller; Katelyn Powell; Julie M Madden; Scott T Eblen; Julie L Boerner
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

8.  Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile.

Authors:  K Graham; A de las Morenas; A Tripathi; C King; M Kavanah; J Mendez; M Stone; J Slama; M Miller; G Antoine; H Willers; P Sebastiani; C L Rosenberg
Journal:  Br J Cancer       Date:  2010-03-02       Impact factor: 7.640

9.  Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin.

Authors:  L S Tain; R B Chowdhury; R N Tao; H Plun-Favreau; N Moisoi; L M Martins; J Downward; A J Whitworth; N Tapon
Journal:  Cell Death Differ       Date:  2009-03-13       Impact factor: 15.828

10.  The germinal center kinase GCK-1 is a negative regulator of MAP kinase activation and apoptosis in the C. elegans germline.

Authors:  Katherine R Schouest; Yasuhiro Kurasawa; Tokiko Furuta; Naoki Hisamoto; Kunihiro Matsumoto; Jill M Schumacher
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.